₹1,026.15
▲ +2.05 +0.20%
17 Jun 2026
NSE Listed · Healthcare
Max Healthcare Institute Limited (MAXHEALTH)
20-day avg volume: 35.3L shares
- Pays a dividend yield of 15.0%.
- Revenue grew 19% YoY.
- Net profit is growing year over year.
- Stock trades at a high P/E of 70.
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Revenue | ₹2,143 Cr | ₹2,068 Cr | ₹2,135 Cr | ₹2,028 Cr | ₹1,910 Cr | — |
| EBITDA | ₹654 Cr | ₹535 Cr | ₹608 Cr | ₹559 Cr | ₹559 Cr | — |
| Net Profit | ₹342 Cr | ₹301 Cr | ₹491 Cr | ₹308 Cr | ₹319 Cr | — |
| EPS | 3.5 | 3.09 | 5.02 | 3.15 | 3.26 | — |
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | ₹8,373 Cr | ₹7,028 Cr | ₹5,309 Cr | ₹4,489 Cr | — |
| EBITDA | ₹2,357 Cr | ₹1,931 Cr | ₹1,655 Cr | ₹1,367 Cr | — |
| Net Profit | ₹1,442 Cr | ₹1,076 Cr | ₹1,058 Cr | ₹1,104 Cr | — |
| EPS | — | 11.01 | 10.84 | 11.36 | 6.24 |
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | ₹17,231 Cr | ₹15,214 Cr | ₹12,000 Cr | ₹10,102 Cr | — |
| Total Liabilities | ₹6,484 Cr | ₹5,834 Cr | ₹3,592 Cr | ₹2,692 Cr | — |
| Equity | ₹10,747 Cr | ₹9,381 Cr | ₹8,408 Cr | ₹7,410 Cr | — |
| Total Debt | ₹3,478 Cr | ₹3,010 Cr | ₹1,295 Cr | ₹908 Cr | — |
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating | ₹1,633 Cr | ₹1,438 Cr | ₹1,122 Cr | ₹1,284 Cr | — |
| Investing | ₹-1,689 Cr | ₹-1,611 Cr | ₹-1,285 Cr | ₹-102 Cr | — |
| Financing | ₹59 Cr | ₹-163 Cr | ₹-264 Cr | ₹-289 Cr | — |
| Free Cash Flow | ₹149 Cr | ₹493 Cr | ₹336 Cr | ₹949 Cr | — |
Healthcare · Medical Care Facilities
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search